ArticleBiomaterials2026
Injectable and self-healing fucoidan hydrogel: A natural anti-inflammatory biomaterial.
Article in Biomaterials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Gummies: From Confectionery to Functional Hydrogel-Based Bioactive Delivery Systems.Gels (Basel, Switzerland) · 2026Review
- Injectable Self-Healing Fucoidan-Chitosan Hydrogel Incorporating Polydopamine-Silver-Rutin Nanoparticles for Multifunctional Wound Dressing.Molecules (Basel, Switzerland) · 2026Article
- Preparation, Characterization, and Evaluation of β-Cyclodextrin Inclusion Hydrogel Films Based on Dates Carboxymethyl Cellulose for Hydrophobic Drug Delivery.Chemistry & biodiversity · 2026Article
- Research Progress on Natural Polysaccharide Hydrogels in the Diagnosis and Treatment of Colorectal Cancer.Gels (Basel, Switzerland) · 2026Review
- Fucoidans as multifunctional marine polysaccharide platforms: From nutritional supplements to advanced drug delivery for cancer therapy.International journal of pharmaceutics: X · 2026Review
- Scalable one-step synthesis of gelatin-dithiolane for neural tissue engineering.Journal of materials chemistry. B · 2026Article
- Fucoidan and alginate from brown seaweeds: extraction, structural diversity, biocompatibility, biodegradability, and biomedical applications.Frontiers in plant science · 2026Review
- Anti-inflammatory effects of natural polysaccharides: molecular mechanisms and nanotherapeutic applications.Frontiers in immunology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Fucoidan, a natural sulfated polysaccharide, offers immense potential as a natural immune-modulatory bioactive polymer to develop hydrogels for tissue engineering. Yet, systematically tunable hydrogels composed primarily of fucoidan, that can also be injected into target tissues to reduce inflammation are still lacking. To address this, we have developed a highly tunable, hydrazone crosslinked fucoidan (hcFu) hydrogel that is injectable and can be utilized for various tissue engineering applications. We demonstrate that chemically modified fucoidan retains its ability to induce macrophage polarization. The hcFu hydrogel can be tuned to achieve gelation rate from instantaneous to over 10 min. Moreover, due to the dynamic nature of hydrazone covalent bonds, fucoidan hydrogel displays viscoelasticity, self-healing, extrudability, injectability, and excellent stability in physiological environments. In-vitro biocompatibility assays confirm its capacity to support cell growth, while in-vitro and in-vivo studies reveal its inherent anti-inflammatory and antioxidant effects. Importantly, hcFu hydrogel effectively modulates immune responses without incorporating additional cytokines. These findings position fucoidan hydrazone as a promising natural anti-inflammatory biomaterial with significant potential for tissue engineering and therapeutic applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.